Professional Summary

Professional Overview

Alex Thurman is a seasoned financial executive with over 20 years of experience in the medical device and pharmaceutical industries. As the Senior Vice President and Chief Financial Officer at Glaukos Corporation, he oversees the company's financial operations, strategic planning, and mergers and acquisitions efforts.

Current Role

In his current role at Glaukos Corporation, Alex is responsible for leading the company's financial strategy, reporting, and compliance initiatives. He plays a crucial role in driving financial performance, managing risk, and supporting the organization's growth objectives. Under his leadership, Glaukos has achieved significant financial milestones and strengthened its market position as a leading innovator in the ophthalmology space.

Career Progression

Prior to joining Glaukos, Alex held several senior finance roles at Allergan, including Senior Director of Finance for the U.S. Medical Aesthetics Division and Senior Director of Corporate Accounting for Mergers and Acquisitions. In these positions, he contributed to the successful integration of acquired companies and drove strategic initiatives that enhanced the company's operational efficiency and profitability.

Before Allergan, Alex served as the Vice President of Finance and Vice President of Global Tax and Administration at Glaukos Corporation, where he played a key role in the company's financial operations and tax strategy. Earlier in his career, he held management roles in international tax at Deloitte and Arthur Andersen, further developing his expertise in tax planning and compliance.

Academic Background

Alex holds a Master of Accountancy (MAcc) and a Bachelor of Science (BS) from Brigham Young University, where he graduated with distinction. His academic achievements demonstrate his strong technical and analytical capabilities, which have been instrumental in his professional success.

Areas of Expertise

Alex's areas of expertise include financial planning and analysis, mergers and acquisitions, tax strategy, and financial reporting. He is adept at leveraging data-driven insights to inform decision-making and drive operational improvements. Additionally, he has a proven track record of leading high-performing teams and collaborating cross-functionally to achieve organizational goals.

Professional Impact

Throughout his career, Alex has contributed to several significant projects and initiatives that have had a positive impact on the medical device and pharmaceutical industries. At Allergan, he played a key role in the integration of acquired companies, ensuring seamless financial and operational transitions. At Glaukos, he has been instrumental in the company's strategic growth and market expansion, contributing to its recognition as a leading innovator in the ophthalmology field.

Conclusion

With his extensive experience, deep industry knowledge, and proven leadership abilities, Alex Thurman is a valuable asset to Glaukos Corporation. As the Senior Vice President and Chief Financial Officer, he is poised to continue driving the company's financial success and supporting its long-term growth and innovation initiatives.